Navigation Links
MedImmune Expands Scientific and Engineering Leadership
Date:12/20/2007

oject management. In 1996, Dr. Stageman led the team that initiated the successful Phase 3 development of Faslodex(R) (fulvestrant). Later, as AZ vice president of biopharmaceutical strategy, he established a team that steered the organization's aggressive drive into biologics, including the acquisitions of both CAT and MedImmune. Dr. Stageman has served on several UK Research Council grant committees and recently served as a member of the Royal Society working party on pharmacogenetics. He is an honorary professor at the University of Manchester and holds both a bachelor of science degree in chemistry and a doctorate in physical chemistry from the University of Bristol.

Jon Green, vice president, business operations is responsible for developing and maintaining all operational, infrastructure and support activities at MedImmune's Cambridge site. Prior to joining CAT in 1992, he held a number of academic posts including on the Medical Research Council, Carshalton, and in the Department of Biochemistry at Imperial College London. Mr. Green holds a primary certification and a master's degree, both in molecular biology. He is a fellow of the Institute of Biology with chartered status.

With 14 years of experience at CAT, Jane Osbourn, Ph.D., currently serves as vice president, research, and acting head, oncology research for MedImmune's Cambridge operations. Previously, she has held a number of product and technology development posts within the organization. Dr. Osbourn completed a doctorate at the John Innes Centre for Plant Science Research in Norwich, followed by a British Heart Foundation Post doctoral fellowship at the Department of Medicine at Addenbrooke's Hospital in Cambridge. She obtained a first-class degree in natural sciences (biochemistry) from the University of Cambridge.

Paul Varley, Ph.D., currently vice president, development, Cambridge, joined CAT in 1998 as director of pharmaceutical sciences and was promoted to vice president o
'/>"/>

SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
4. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
5. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
6. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
7. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
8. Rohm and Haas Expands in India
9. Concentra Expands Horizon Air Employee Health Program With On-Site Clinic
10. Regional Center of Orange County Expands Family Support Resources to Meet Growing Needs
11. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... July 9, 2014 There has been a sharp ... Southwestern Medical Center using MyChart, the online, interactive service ... communicate with their healthcare providers, schedule appointments, and renew ... patients actively using MyChart each year increased ... increased more than 10-fold, according to a study by ...
(Date:7/9/2014)... extinctions around the world have been linked to ... research from the National Institute for Mathematical and ... may also contribute. , In a series ... causes severe hemorrhage of internal organs in frogs, ... frogs if they are exposed to the virus ...
(Date:7/9/2014)... may smell of flatulence and have a reputation for being ... hydrogen sulfide is now being being found to offer potential ... stroke, heart attacks and dementia. A new compound (AP39), designed ... key to future therapies, by targeting delivery of very small ... inside cells. , Scientists in Exeter have already found ...
(Date:7/9/2014)... is one of the most important organs in the ... utilize our food properly this is its synthesis ... our organism this is its detoxification function. Lack ... food all damage the liver. The resulting diseased cells ... and life-threatening liver failure. According to the German Liver ...
(Date:7/9/2014)... poor printing on prescription labels handed out by ... errors in taking medication, according to new research ... National Institute for the Blind)., The study, published ... found that labels on prescription medications dispensed by ... for legibility. , By simply following recommended guidelines ...
Breaking Medicine News(10 mins):Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3Health News:Study predicts ranavirus as potential new culprit in amphibian extinctions 2Health News:Rotten egg gas holds key to healthcare therapies 2Health News:Telemedicine for patients with chronic liver diseases 2Health News:Telemedicine for patients with chronic liver diseases 3Health News:Most prescription labels fail to meet guidelines, risking dosage errors 2
... an inherited disease that clogs airways with thick mucous, ... life expectancy for children with cystic fibrosis has increased ... shortened in young adulthood by the ravages of lung ... common, environmental microbes that mutate in ways that let ...
... are offering pediatric patients diagnosed with chronic illnesses acupuncture ... effects like nausea, fatigue, and vomiting caused by chronic ... Chinese and Western medicine at Rush Children,s Hospital is ... acupuncture might help in reducing pain in children and ...
... ... to address childhood obesity, a risk factor for a number of chronic diseases including diabetes, ... ... today launched a major campaign to address childhood obesity, a risk factor for a number ...
... , ... Sunquest Collection Manager™ increases patient safety through accuracy and timeliness , ... (PRWEB) February 9, ... and outreach solutions, announced today that the University of Virginia Health System Medical ...
... recurrence-free, research shows , TUESDAY, Feb. 9 (HealthDay News) ... play a part in prognosis with non-small cell lung cancers, ... of the patient. , The researchers analyzed genetic and clinical ... on sex and age (below or above age 70). The ...
... begins in the womb, expert says, , TUESDAY, Feb. 9 ... of milk and have a high dietary intake of vitamin ... multiple sclerosis later in life, researchers say. , The new ... their experiences and diet during pregnancy. The nurses were followed ...
Cached Medicine News:Health News:Adapting to clogged airways makes common pathogen resist powerful drugs 2Health News:Adapting to clogged airways makes common pathogen resist powerful drugs 3Health News:Young patients with chronic illnesses find relief in acupuncture 2Health News:National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal 2Health News:National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal 3Health News:University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution 2Health News:University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution 3Health News:Genes Play Role in Prognosis With Non-Small Cell Lung Cancers 2Health News:Drinking Milk While Pregnant May Lower Kids' MS Risk 2
(Date:1/15/2014)... BOSTON , Jan. 15, 2014 Tegra Medical is ... Mark King as its new Chief Executive Officer.  Mark ... in which he has overseen the company,s four facilities in ... and Costa Rica.  Mr. King joined Tegra Medical in 2012 ...
(Date:1/15/2014)...  According to Millennium Research Group (MRG), the global ... the United States and European transcatheter ... moderately through 2022, with embolization particles representing one ... in drug-eluting beads (DEBs) and radioembolization spheres in ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... DIEGO, Nov. 8, 2010 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... three and nine months ended September 30, 2010. ... prudent cash management and reflected $29.3 million in cash at ... ADVENTRX.  "We recently submitted a New Drug Application to the ...
... 2010 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: SHP ... and biotechnology research and development outsourcing company, today announced ... the Company,s Board of Directors and Audit Committee, effective ... Officer and Chief Operating Officer of ShangPharma, will resign ...
Cached Medicine Technology:ADVENTRX Reports Third Quarter Financial Results 2ADVENTRX Reports Third Quarter Financial Results 3ADVENTRX Reports Third Quarter Financial Results 4ADVENTRX Reports Third Quarter Financial Results 5ADVENTRX Reports Third Quarter Financial Results 6ShangPharma Announces Appointment of Benson Tsang as a Member of the Board of Directors and Audit Committee 2
... Featuring an expanded database containing over ... identification cards, VITEK 2 Compact offers ... amount of time (2 to 14 ... of microorganisms that contaminate production areas ...
... transmitting data from multiple sources is ... Dawnings ResultNet/Plus software allows you to ... your communications network., ,ResultNet/Plus eliminates the ... from largescale or multi-site laboratories to ...
... Software is a powerful Java-based interface ... to control laboratory instrument connections and ... used in two applications: embedded in ... on a network PC station. Within ...
Powerful LED Illumination , The ultrabright and compact 3S LED HeadLight from HEINE for Powerful, coaxial illumination...
Medicine Products: